Armata Pharmaceuticals, Inc.(NYSE Amex Equities : ARMP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 26.11% | 281.87 | 1.4% | $749.34m | |
| AMGN | Amgen, Inc. | 0.94% | 204.83 | 1.3% | $389.48m | |
| CELG | Celgene Corp. | 1.26% | 104.70 | 1.3% | $375.89m | |
| GILD | Gilead Sciences, Inc. | 1.00% | 65.86 | 1.0% | $371.46m | |
| ILMN | Illumina, Inc. | -1.52% | 309.05 | 3.5% | $230.08m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 4.10% | 191.06 | 1.9% | $217.62m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.11% | 301.31 | 2.6% | $207.80m | |
| EXAS | EXACT Sciences Corp. | -4.25% | 88.85 | 24.0% | $175.92m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.44% | 99.28 | 1.9% | $169.24m | |
| A | Agilent Technologies, Inc. | -1.05% | 74.69 | 1.6% | $132.10m | |
| SGEN | Seattle Genetics, Inc. | -2.23% | 98.64 | 6.2% | $130.55m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.24% | 85.55 | 14.6% | $127.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.01% | 67.73 | 4.3% | $95.03m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.21% | 18.88 | 10.2% | $94.86m | |
| NKTR | Nektar Therapeutics | -2.99% | 17.20 | 5.5% | $82.10m |
Company Profile
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.